Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.
Market Analysis and Insights: Global and United States Standard Lancets Market
This report focuses on global and United States Standard Lancets market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Standard Lancets market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Needle accounting for % of the Standard Lancets global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Hospitals and Clinics was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Standard Lancets market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Standard Lancets Scope and Market Size
Standard Lancets market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Standard Lancets market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Standard Lancets market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Needle
Blade
Segment by Application
Hospitals and Clinics
Homecare Settings
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Roche
Lifescan
BD
Bayer
Abbott
B. Braun
ARKRAY
Terumo
I-SENS
Nipro
Omron
Infopia
AgaMatrix
Smiths Medical
Sarstedt
SANNUO
Yicheng
Yuwell
Greiner Bio One
Edan
Narang Medical